Computed from published fixed rules, not a model's judgement — though one input, the count of high-severity risks, comes from the AI analysis below.
Not investment advice and not a price target: it scores the quarter's fundamentals, not the stock. Full methodology →
AI Takeaway
Alexandria Real Estate Equities (ARE) reported a net loss of $1.43B in FY2025, a dramatic swing from $323M profit in FY2024, driven by significant asset impairments and write-downs, while operating cash flow remained positive at $1.41B.
EPS (Diluted)
-$8.44
-568.89% YoY
Source: SEC XBRL
ARE generated $1.41B of operating cash flow in FY2025, down 6.0% year over year.
Last 4 quarters: 1 beat
| Quarter | Actual EPS (USD) | Consensus (USD) | Result |
|---|---|---|---|
| Jun 2026 | -0.43 | 0.87 | Miss -149.3% |
| Mar 2026 | 2.10 | 0.13 | Beat +1459.0% |
| Dec 2025This filing | -6.35 | 0.28 | Miss -2332.0% |
| Sep 2025 | -1.38 | 0.50 | Miss -374.4% |
Reported EPS of -$6.35 versus the $0.28 analyst consensus — a -2332.0% miss for Dec 2025.
Compiled by AI from this SEC filing
ARE swung to a net loss of $1.43B in FY2025 from net income of $323M in FY2024, a YoY decline of 542.7%, primarily attributable to large non-cash impairment charges on its life science real estate portfolio amid a challenging leasing environment.
Source: 10-K Income Statement
Total assets fell 9.2% YoY to $34.08B from $37.53B, reflecting asset dispositions and impairment write-downs, consistent with the company's strategy to recycle capital and reduce exposure to weaker markets.
Source: 10-K Balance Sheet
Investing cash flow turned sharply positive to $362M in FY2025 from -$1.51B in FY2024, a 124% improvement, indicating significant proceeds from property dispositions as ARE accelerated its asset monetization program.
Source: 10-K Cash Flow Statement
Despite the large net loss, operating cash flow remained robust at $1.41B (down only 6.0% YoY from $1.50B), demonstrating that core rental income continues to generate meaningful cash, with the net loss largely driven by non-cash charges.
Source: 10-K Cash Flow Statement
Share repurchases surged 315.5% YoY to $208M from $50M, suggesting management views the stock as undervalued and is returning capital to shareholders even as it manages its balance sheet through asset sales.
Source: 10-K Cash Flow Statement
Compiled by AI from this SEC filing · 2 high, 3 medium, 0 low
ARE's portfolio is heavily concentrated in life science and laboratory real estate, a sector facing elevated vacancy rates and reduced demand from biotech tenants amid funding pressures. This concentration risk contributed to significant impairment charges in FY2025 and could persist if the sector does not recover.
Source: 10-K Balance Sheet & Income Statement
Stockholders' equity declined 13.5% YoY to $15.47B, reflecting the impact of impairment write-downs on the asset base. Continued impairments could further erode book value and pressure the company's financial ratios.
Source: 10-K Balance Sheet
Long-term debt stands at $12.40B, representing a debt-to-equity ratio of approximately 0.96x. With rising interest rates and a weakening asset base, refinancing risk and interest coverage could become a concern if operating cash flows deteriorate.
Source: 10-K Balance Sheet
ROE of -9.24% and ROA of -4.19% indicate that ARE is currently destroying value on both an equity and asset basis. While largely driven by non-cash impairments, sustained negative returns could affect investor confidence and cost of capital.
Source: 10-K Key Ratios
Financing cash flow was -$1.78B in FY2025 versus -$93M in FY2024, a 1,811.6% increase in outflows, driven by debt repayments and increased buybacks. This significant cash usage limits financial flexibility if market conditions worsen.
Source: 10-K Cash Flow Statement
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Net Income $B | -1.43 $B | 0.32 $B | -542.66% |
EPS (Basic) $ | -8.44 $ | 1.80 $ | -568.89% |
EPS (Diluted) $ | -8.44 $ | 1.80 $ | -568.89% |
Answers draw on this SEC filing and the data on this page
Alexandria Real Estate Equities reported a Q2 FY2026 FFO of $1.73 per share, with net loss narrowing to $0.43 per share, as record leasing volume and capital recycling efforts partially mitigated headwinds from oversupply and rising vacancy.
Alexandria Real Estate Equities (ARE) delivered a dramatic Q1 FY2026 turnaround with net income surging to $361.7M from a prior-year loss of $8.9M, driven by asset dispositions and debt reduction, even as total assets contracted 9.1% YoY.
Other companies in Office REITs